R1 RCM Inc. (RCM)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
R1 RCM Inc. (RCM) trades at $14.31 with AI Score 54/100 (Grade B). R1 RCM Inc. provides technology-driven revenue cycle management solutions for healthcare providers, aiming to improve financial performance and patient experience. Market cap: $6.04B, Sector: Healthcare.
Price live · AI analysis from May 10, 2026Analyst Coverage for RCM: RCM does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates RCM against Healthcare peers across nine fundamental dimensions and assigns a mixed fundamental profile based on the underlying data.
RCM: 3/7 perspectives are bullish. Dominant signal: Ray Dalio bullish.
How is this calculated? →R1 RCM Inc. (RCM) Healthcare & Pipeline Overview
R1 RCM Inc. delivers technology-driven revenue cycle management (RCM) solutions for hospitals, health systems, and medical groups, focusing on enhancing patient experience and financial outcomes. The company's comprehensive suite of services and software-as-a-service offerings position it as a key player in the healthcare information services sector.
What Is the Investment Thesis for RCM?
R1 RCM presents a notable research candidate within the healthcare information services sector. The company's focus on technology-driven revenue cycle management (RCM) solutions aligns with the growing need for healthcare providers to improve financial performance and patient experience. With a market capitalization of $6.04B and a beta of 0.84, R1 RCM demonstrates stability within a dynamic market. Key growth catalysts include the increasing adoption of RCM outsourcing by hospitals and health systems, driven by regulatory complexities and the need for cost optimization. The company's modular service offerings provide flexibility and scalability, attracting a wider range of clients. However, investors should be aware of potential risks such as increasing competition and the impact of changes in healthcare regulations.
Based on FMP financials and quantitative analysis
RCM Key Highlights
- Market capitalization of $6.04B indicates substantial investor confidence in R1 RCM's market position.
- P/E ratio of 1815.1 suggests high growth expectations, reflecting investor anticipation of future earnings potential.
- Gross margin of 21.5% demonstrates the company's ability to generate revenue from its services.
- The company employs 29,400 individuals, highlighting its significant operational scale and service delivery capacity.
- R1 RCM's solutions are technology-driven, indicating a focus on innovation and efficiency in revenue cycle management.
Who Are RCM's Competitors?
RCM is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| LHCG LHC Group, Inc. | $169.81 | +0.00% | $5.29B | 45 |
| ISEE IVERIC bio, Inc. | $39.95 | +0.38% | $5.51B | 47 |
| NARI Inari Medical, Inc. | $79.97 | +0.00% | $4.68B | 57 |
| ONEM ONEM | $16.47 | +0.00% | $3.40B | 55 |
| CARL CARLSMED, INC. | $11.90 | +4.94% | $323.50M | 70 |
| HNGE Hinge Health, Inc. | $89.42 | +6.39% | $6.92B | 68 |
| VRHI Veri Medtech Holdings Inc. | $1.95 | +0.00% | $39.09M | 67 |
| AKLI Akili, Inc. | $0.43 | +0.25% | $34.10M | 67 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are RCM's Key Strengths?
- Comprehensive suite of RCM services.
- Technology-driven solutions and automation capabilities.
- Established relationships with major healthcare providers.
- Strong focus on improving patient experience.
What Are RCM's Weaknesses?
- Relatively low profit margin of 0.1%.
- High P/E ratio of 1815.1 may indicate overvaluation.
- Dependence on the healthcare industry and regulatory environment.
- Potential for increased competition in the RCM market.
What Could Drive RCM Stock Higher?
- Implementation of new technology solutions to improve efficiency and accuracy in RCM processes.
- Expansion of strategic partnerships with healthcare providers to broaden market reach.
- Increasing adoption of RCM outsourcing by hospitals and health systems.
- Potential acquisitions of companies with complementary technologies or expertise.
What Are the Key Risks for RCM?
- Financial-distress signal — its Altman Z-Score of 1.74 sits in the distress zone (elevated bankruptcy risk).
- Weak fundamentals — a Piotroski F-Score of 3/9 flags soft profitability, leverage or efficiency.
- Rich valuation — a P/E of 1815.1 runs well above the Healthcare sector’s ~23x, leaving little room for a miss.
- Changes in healthcare regulations and reimbursement policies could impact revenue.
- Increasing competition from other RCM providers may put pressure on pricing.
- Cybersecurity risks and data breaches could damage reputation and financial performance.
- Economic downturn and reduced healthcare spending could affect demand for RCM services.
What Are the Growth Opportunities for RCM?
- Expansion of End-to-End RCM Solutions: R1 RCM can capitalize on the increasing trend of hospitals and health systems outsourcing their entire revenue cycle management process. The global revenue cycle management market is projected to reach $107.4 billion by 2029, growing at a CAGR of 12.4% from 2022. By offering comprehensive solutions, R1 RCM can attract larger clients seeking to streamline operations and improve financial outcomes. This expansion requires continued investment in technology and service delivery infrastructure.
- Growth in Modular Service Offerings: R1 RCM's modular services, such as physician advisory and coding management, provide flexibility for clients who prefer to outsource specific components of their revenue cycle. This approach allows the company to cater to a wider range of clients with varying needs and budgets. The market for healthcare BPO is expected to grow significantly, offering substantial opportunities for R1 RCM to expand its modular service offerings. This strategy enables R1 RCM to penetrate niche markets and build long-term relationships with clients.
- Strategic Acquisitions and Partnerships: R1 RCM can pursue strategic acquisitions and partnerships to expand its service offerings and geographic reach. By acquiring companies with complementary technologies or expertise, R1 RCM can enhance its competitive position and accelerate growth. Partnerships with healthcare providers and technology vendors can also create synergistic opportunities. This inorganic growth strategy can provide R1 RCM with access to new markets and technologies, driving long-term value creation.
- Leveraging Technology and Automation: Investing in advanced technologies such as artificial intelligence (AI) and robotic process automation (RPA) can enable R1 RCM to improve efficiency, reduce costs, and enhance the accuracy of its revenue cycle management services. By automating routine tasks and leveraging AI-powered analytics, R1 RCM can optimize workflows and improve revenue capture for its clients. This technology-driven approach can differentiate R1 RCM from its competitors and attract clients seeking innovative solutions.
- Focus on Patient Experience: R1 RCM can differentiate itself by focusing on improving the patient experience throughout the revenue cycle. By implementing patient-friendly billing practices, providing transparent communication, and offering convenient payment options, R1 RCM can enhance patient satisfaction and loyalty for its clients. This patient-centric approach can help healthcare providers improve their reputation and attract more patients. R1 RCM can leverage technology to personalize the patient experience and streamline interactions.
What Opportunities Does RCM Have?
- Expansion of end-to-end RCM solutions to new clients.
- Growth in modular service offerings and strategic partnerships.
- Leveraging technology and AI to improve efficiency and accuracy.
- Focusing on patient experience to differentiate from competitors.
What Threats Does RCM Face?
- Changes in healthcare regulations and reimbursement policies.
- Increasing competition from other RCM providers.
- Cybersecurity risks and data breaches.
- Economic downturn and reduced healthcare spending.
What Are RCM's Competitive Advantages?
- Specialized Expertise: Deep understanding of healthcare revenue cycle management and regulatory requirements.
- Technology-Driven Solutions: Proprietary software and analytics tools that improve efficiency and accuracy.
- Scalability: Ability to handle large volumes of transactions and data for hospitals and health systems.
- Established Relationships: Long-term contracts with major healthcare providers.
What Does RCM Do?
Founded in 2003 and headquartered in Murray, Utah, R1 RCM Inc. has evolved into a leading provider of technology-driven solutions for healthcare providers. The company's core focus is on transforming the patient experience and improving the financial performance of hospitals, health systems, and medical groups through comprehensive revenue cycle management (RCM) services. R1 RCM offers end-to-end RCM solutions that address the entire spectrum of revenue cycle challenges, from patient access and clinical documentation to billing and collections. In addition to its end-to-end offerings, R1 RCM provides a range of modular services, including physician advisory services, which assist healthcare organizations in complying with payer requirements for classifying hospital visits. The company also offers practice management services, revenue integrity solutions, coding management services, patient experience solutions, and business office services. Furthermore, R1 RCM provides software-as-a-service (SaaS) based scheduling and patient access solutions, enhancing its technology-driven approach to healthcare revenue cycle management. R1 RCM's solutions are designed to streamline operations, reduce costs, and improve revenue capture for healthcare providers, positioning the company as a strategic partner in the evolving healthcare landscape.
What Products and Services Does RCM Offer?
- Provides end-to-end revenue cycle management (RCM) services for hospitals and health systems.
- Offers modular services like physician advisory, practice management, and coding management.
- Assists healthcare organizations in complying with payer requirements.
- Provides administrative and operational support for patient care.
- Offers revenue integrity solutions, including charge capture and pricing services.
- Delivers software-as-a-service (SaaS) based scheduling and patient access solutions.
- Transforms the patient experience and financial performance of healthcare providers.
How Does RCM Make Money?
- Generates revenue by providing end-to-end revenue cycle management (RCM) services to hospitals and health systems.
- Earns fees from modular services such as physician advisory, practice management, and coding management.
- Offers software-as-a-service (SaaS) based scheduling and patient access solutions, generating recurring revenue.
- Provides revenue integrity solutions, including charge capture, charge description master maintenance, and pricing services.
What Industry Does RCM Operate In?
R1 RCM operates in the healthcare information services sector, a market characterized by increasing demand for technology-driven solutions that improve efficiency and reduce costs for healthcare providers. The industry is driven by factors such as regulatory complexities, the shift towards value-based care, and the growing need for data analytics to optimize revenue cycle management. The competitive landscape includes companies like LHC Group, Inc. (LHCG), IVERIC bio, Inc. (ISEE), Inari Medical, Inc. (NARI), and ONEM, each offering various solutions within the healthcare services market. R1 RCM differentiates itself through its comprehensive suite of end-to-end and modular RCM services, as well as its focus on technology and patient experience.
Who Are RCM's Key Customers?
- Hospitals seeking to improve their financial performance and streamline operations.
- Health systems looking for comprehensive revenue cycle management solutions.
- Medical groups needing administrative and operational support for patient care.
- Healthcare organizations requiring assistance with payer compliance and coding management.
Net sellingInsider Activity
The most recent 9 insider filings for R1 RCM Inc. break down as 7 sales and 2 purchases. On net that is roughly 15.8M shares disposed (about $210.7M), a signal worth weighing alongside the fundamentals.
FY2026 estForward Outlook
Wall Street analysts project R1 RCM Inc. revenue of about $3.15B for fiscal 2026, with EPS near $0.29. The estimate reflects 6 contributing analysts.
F-Score 3/9Financial Health
R1 RCM Inc.'s Piotroski F-Score is 3/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of 1.74 places it in the distress zone, a signal of elevated financial risk.
ROE 0%Key Financial Metrics
Return on equity for R1 RCM Inc. stands at 0.1%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 0.1%, showing how much profit it generates from its asset base. Its free cash flow yield is 3.9%, a gauge of the cash the business throws off relative to its market value. A current ratio of 1.83 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is 0.1%, the inverse of the P/E and a quick read on earnings relative to price.
R1 RCM Inc. (RCM) Valuation Context
Valued at $6.04B, RCM is classified as a mid-cap stock. Relative to its peer group, RCM's quantitative score of 54/100 is roughly in line with the peer average of 55/100.
Company Profile
R1 RCM Inc. operates in the Medical - Healthcare Information Services industry within the Healthcare sector. It is headquartered in Murray, US. The company is led by CEO Lee Rivas. RCM has traded publicly since 2017.
RCM Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis
Bull Case vs Bear Case
Bull Case
- Comprehensive suite of RCM services.
- Technology-driven solutions and automation capabilities.
- Established relationships with major healthcare providers.
- Strong focus on improving patient experience.
Bear Case
- Relatively low profit margin of 0.1%.
- High P/E ratio of 1815.1 may indicate overvaluation.
- Dependence on the healthcare industry and regulatory environment.
- Potential for increased competition in the RCM market.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · July 2026
RCM Latest News
-
Record Currency Management Participates in Innovative European Bank for Reconstruction and Development (EBRD) -Backed Mongolian Tugrik Transaction
businesswire.com · Jun 19, 2026
-
RCM Services Provider Fellow Health Partners Announces Strategic Investment from Cleargate Capital Partners
businesswire.com · Jun 16, 2026
RCM Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for RCM.
Price Targets
Wall Street price target analysis for RCM.
RCM MoonshotScore
What does this score mean?
The MoonshotScore rates RCM's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Latest News
Record Currency Management Participates in Innovative European Bank for Reconstruction and Development (EBRD) -Backed Mongolian Tugrik Transaction
RCM Services Provider Fellow Health Partners Announces Strategic Investment from Cleargate Capital Partners
Leadership: Lee Rivas
CEO
Lee Rivas is the CEO of R1 RCM Inc., bringing extensive experience in healthcare technology and services. Prior to joining R1 RCM, Rivas held leadership positions at various healthcare companies, focusing on driving innovation and improving operational efficiency. His background includes a strong track record in strategic planning, business development, and technology implementation. Rivas's expertise spans across various aspects of the healthcare industry, including revenue cycle management, clinical operations, and patient engagement.
Track Record: Since becoming CEO, Lee Rivas has focused on expanding R1 RCM's market presence and enhancing its technology-driven solutions. Key achievements include strategic acquisitions, partnerships, and the implementation of advanced technologies such as AI and RPA. Under his leadership, R1 RCM has continued to strengthen its relationships with major healthcare providers and improve its financial performance. Rivas has also emphasized the importance of patient experience and innovation in driving long-term growth.
RCM Healthcare Stock FAQ
What does R1 RCM Inc. do?
R1 RCM Inc. provides technology-driven solutions and services to healthcare providers, primarily focusing on revenue cycle management (RCM). The company offers end-to-end and modular RCM solutions designed to improve the financial performance and patient experience of hospitals, health systems, and medical groups. R1 RCM's services include physician advisory, practice management, coding management, and software-as-a-service (SaaS) based scheduling and patient access solutions. By streamlining operations and optimizing revenue capture, R1 RCM helps healthcare providers navigate the complexities of the healthcare industry and achieve their financial goals.
What do analysts say about RCM stock?
Analyst consensus on R1 RCM (RCM) stock reflects expectations of continued growth driven by the increasing demand for revenue cycle management solutions in the healthcare sector. Key valuation metrics, such as the P/E ratio, suggest high growth expectations. Analysts are closely monitoring the company's ability to expand its market share, integrate new technologies, and maintain profitability. While opinions vary, the overall sentiment is cautiously optimistic, with analysts acknowledging both the growth potential and the inherent risks associated with the healthcare industry and regulatory environment. Investors should conduct their own due diligence and consider their individual risk tolerance before making investment decisions.
What are the main risks for RCM?
R1 RCM faces several risks inherent to the healthcare information services sector. Changes in healthcare regulations and reimbursement policies could significantly impact the company's revenue and profitability. Increasing competition from other RCM providers may put pressure on pricing and market share. Cybersecurity risks and data breaches pose a threat to the company's reputation and financial performance. Economic downturns and reduced healthcare spending could affect demand for RCM services. Additionally, the company's reliance on technology and automation exposes it to risks associated with system failures and technological obsolescence. Effective risk management and mitigation strategies are crucial for R1 RCM to navigate these challenges and sustain long-term growth.
What are the key factors to evaluate for RCM?
R1 RCM Inc. (RCM) holds an AI score of 54/100 (moderate). P/E: 1815.1x vs the S&P 500's ~20-25x. Not financial advice.
How frequently does RCM data refresh on this page?
RCM prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven RCM's recent stock price performance?
R1 RCM Inc. (RCM) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Comprehensive suite of RCM services. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider RCM overvalued or undervalued right now?
R1 RCM Inc. (RCM) trades at 1815.1x earnings. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
What research should beginners do before buying RCM?
Before investing in R1 RCM Inc. (RCM), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Information is based on available data and may be subject to change.
- Financial metrics are as of the latest available reporting period.